Literature DB >> 29846837

Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping.

Bo Da Nam1,2, Sung Mok Kim3,4,5, Hye Na Jung1,6, Yiseul Kim1, Yeon Hyeon Choe1,7.   

Abstract

To compare inversion time (TI) parameters, native T1, and extracellular volume (ECV) on cardiac magnetic resonance (CMR) imaging between patients with cardiac amyloidosis (CA) or hypertrophic cardiomyopathy (HCMP). Forty six patients with biopsy-confirmed CA and 30 patients with HCMP who underwent CMR were included. T1 and TI values were measured in the septum and cavity of the left ventricle on T1 mapping and TI scout images. TI values were selected at nulling point for each myocardium and blood pool. Native T1, ECV, and TI interval values were significantly different between the CA (1170.5 ± 86.4 ms, 56.7 ± 12.2, - 11.5 ± 28.4 ms) and HCMP (1059.5 ± 63.4 ms, 28.5 ± 5.8, 66.2 ± 25.4 ms) (all p < 0.001). The diagnostic performance of the TI interval (area under the ROC curve, 0.975) was not inferior to that of the ECV (0.980, p = 0.776), and it was superior to that of the native T1 (0.845, p = 0.004). The diagnostic performance of TI interval was comparable to that of ECV for differential diagnosis between CA and HCMP. TI interval showed the feasibility as quantitative CMR parameter when T1 mapping images are not available.

Entities:  

Keywords:  Amyloidosis; Cardiovascular magnetic resonance; Extracellular volume; Hypertrophic cardiomyopathy; Inversion time

Mesh:

Year:  2018        PMID: 29846837     DOI: 10.1007/s10554-018-1385-2

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  24 in total

1.  T1 mapping shows increased extracellular matrix size in the myocardium due to amyloid depositions.

Authors:  Lourens F H J Robbers; Emma N Baars; Wessel P Brouwer; Aernout M Beek; Mark B M Hofman; Hans W M Niessen; Albert C van Rossum; C Bogdan Marcu
Journal:  Circ Cardiovasc Imaging       Date:  2012-05-01       Impact factor: 7.792

2.  Quantification of extracellular matrix expansion by CMR in infiltrative heart disease.

Authors:  François-Pierre Mongeon; Michael Jerosch-Herold; Otávio Rizzi Coelho-Filho; Ron Blankstein; Rodney H Falk; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2012-09

3.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

4.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

5.  Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease.

Authors:  L D Diesbourg; F S Prato; G Wisenberg; D J Drost; T P Marshall; S E Carroll; B O'Neill
Journal:  Magn Reson Med       Date:  1992-02       Impact factor: 4.668

6.  Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  James M Wilson; Rollo P Villareal; Ramesh Hariharan; Ali Massumi; Raja Muthupillai; Scott D Flamm
Journal:  Tex Heart Inst J       Date:  2002

7.  Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases.

Authors:  R A Kyle; P R Greipp; W M O'Fallon
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

8.  Native T1 mapping in transthyretin amyloidosis.

Authors:  Marianna Fontana; Sanjay M Banypersad; Thomas A Treibel; Viviana Maestrini; Daniel M Sado; Steven K White; Silvia Pica; Silvia Castelletti; Stefan K Piechnik; Matthew D Robson; Janet A Gilbertson; Dorota Rowczenio; David F Hutt; Helen J Lachmann; Ashutosh D Wechalekar; Carol J Whelan; Julian D Gillmore; Philip N Hawkins; James C Moon
Journal:  JACC Cardiovasc Imaging       Date:  2014-01-08

Review 9.  Cardiovascular Magnetic Resonance Imaging of Myocardial Interstitial Expansion in Hypertrophic Cardiomyopathy.

Authors:  Timothy C Wong
Journal:  Curr Cardiovasc Imaging Rep       Date:  2014

10.  T1 mapping: characterisation of myocardial interstitial space.

Authors:  Rosario J Perea; Jose T Ortiz-Perez; Manel Sole; M Teresa Cibeira; Teresa M de Caralt; Susanna Prat-Gonzalez; Xavier Bosch; Antonio Berruezo; Marcelo Sanchez; Joan Blade
Journal:  Insights Imaging       Date:  2014-11-26
View more
  4 in total

Review 1.  Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.

Authors:  Manhal Habib; Sara Hoss; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2019-06-26       Impact factor: 2.931

2.  Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.

Authors:  Jack Brownrigg; Massimiliano Lorenzini; Matthew Lumley; Perry Elliott
Journal:  ESC Heart Fail       Date:  2019-09-05

Review 3.  Anatomical-MRI Correlations in Adults and Children with Hypertrophic Cardiomyopathy.

Authors:  Radu Ovidiu Rosu; Ana Lupsor; Alexandru Necula; Gabriel Cismaru; Simona Sorana Cainap; Daniela Iacob; Cecilia Lazea; Andrei Cismaru; Alina Gabriela Negru; Dana Pop; Gabriel Gusetu
Journal:  Diagnostics (Basel)       Date:  2022-02-14

4.  Prediction Value of Epilepsy Secondary to Inferior Cavity Hemorrhage Based on Scalp EEG Wave Pattern in Deep Learning.

Authors:  Shishuang Jiang; Xuenong He
Journal:  J Healthc Eng       Date:  2022-03-15       Impact factor: 2.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.